Close Menu

Takara Bio

Aviir has launched two comprehensive genetic panels to test for undiagnosed arrhythmia or cardiomyopathy. The tests cover the major causes of cardiomyopathies, arrhythmia disorders, and other genetically transmitted diseases that affect the heart and vasculature.

Life Technologies' Ion Torrent has launched new versions of its PGM chips that increase throughput.

NEW YORK (GenomeWeb News) – Invivoscribe Technologies today said that a German court has ruled in its favor in a patent dispute over FLT3 testing technology.

NEW YORK (GenomeWeb News) – WaferGen BioSystems said in a regulatory document that revenues for its first quarter more than doubled year over year.
It separately also announced a stock sale by shareholders of up to more than 112 million shares.

WaferGen Biosystems this week launched the SmartChip TE, a PCR-based target-enrichment product for sample preparation prior to targeted re-sequencing on next-generation platforms.

Name: Andrew Brooks
Title: Chief operating officer, RUCDR Infinite Biologics

NEW YORK (GenomeWeb News) – WaferGen Biosystems reported that its fourth-quarter revenues increased more than 700 percent year over year as sales of its PCR products grew.

WaferGen Biosystems said this week that the Salk Institute for Biological Studies has established a nano-qPCR core laboratory that will feature a WaferGen SmartChip system for high-throughput, real-time PCR studies.

WaferGen Biosystems said this week that it has inked a co-marketing agreement with Qiagen KK, Qiagen's Japanese subsidiary, to jointly promote WaferGen's SmartChip Real-Time PCR system and consumable chips with Qiagen's PCR assays and, eventually, sequencing products.

NEW YORK (GenomeWeb News) — WaferGen Biosystems and Qiagen KK, the Japanese subsidiary of Qiagen, said today that they have inked a co-marketing agreement for genomics products.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.